Difference between revisions of "AB-CHMINACA"
From Wiki Weed
(Created page with "AB-CHMINACA is an indazole-based synthetic cannabinoid. It is a potent agonist of the CB1 receptor. == Side Effects == There have been a number of reported cases of sei...") |
|||
| Line 1: | Line 1: | ||
AB-CHMINACA is an indazole-based synthetic cannabinoid. It is a potent agonist of the [[CB1]] receptor. | AB-CHMINACA is an indazole-based synthetic cannabinoid. It is a potent agonist of the [[CB1]] receptor. | ||
| − | |||
== Side Effects == | == Side Effects == | ||
There have been a number of reported cases of seizures, deaths, and psychotic episodes in relation to this synthetic cannabinoid | There have been a number of reported cases of seizures, deaths, and psychotic episodes in relation to this synthetic cannabinoid | ||
| − | |||
== Legal status == | == Legal status == | ||
Latest revision as of 18:24, 14 February 2015
AB-CHMINACA is an indazole-based synthetic cannabinoid. It is a potent agonist of the CB1 receptor.
Side Effects
There have been a number of reported cases of seizures, deaths, and psychotic episodes in relation to this synthetic cannabinoid
Legal status
| Country | Date of Ban | Notes |
|---|---|---|
| U.S.A. | 20th January 2015 | Schedule 1 |
| United Kingdom | Currently un-scheduled |
